/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of approximately $50.8 billion, Cencora, Inc. (COR) is one of the world’s largest pharmaceutical services and drug distribution companies, providing healthcare products, specialty medicines, and supply chain solutions to pharmacies, hospitals, physician practices, and healthcare providers globally. Headquartered in Conshohocken, Pennsylvania, the company plays a critical role in the pharmaceutical supply chain by helping deliver medications efficiently and securely across the healthcare system.
The pharma distributor has lagged behind the broader market over the past year. COR stock has dipped 8.4% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 26.5% gains. In 2026, the stock is down 24.3%, trailing the index’s 8.8% rise.